Literature DB >> 1526645

Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.

A Tärnvik, M Eriksson, G Sandström, A Sjöstedt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1526645      PMCID: PMC1421695     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  86 in total

1.  Failure of killed Listeria monocytogenes vaccine to produce protective immunity.

Authors:  C H von Koenig; H Finger; H Hof
Journal:  Nature       Date:  1982-05-20       Impact factor: 49.962

2.  A wild and an attenuated strain of Francisella tularensis differ in susceptibility to hypochlorous acid: a possible explanation of their different handling by polymorphonuclear leukocytes.

Authors:  S Löfgren; A Tärnvik; M Thore; J Carlsson
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

Review 3.  The role of cell-mediated immunity in bacterial infections.

Authors:  H Hahn; S H Kaufmann
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

4.  Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon.

Authors:  A F Kiderlen; S H Kaufmann; M L Lohmann-Matthes
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

5.  A whole-blood lymphocyte stimulation test for the diagnosis of human tularemia.

Authors:  H Syrjälä; E Herva; J Ilonen; K Saukkonen; A Salminen
Journal:  J Infect Dis       Date:  1984-12       Impact factor: 5.226

6.  Infection-immunity in tularemia: specificity of cellular immunity.

Authors:  J L Claflin; C L Larson
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

7.  In vitro interactions between rabbit alveolar macrophages and Pasteurella tularensis.

Authors:  J E Nutter; Q N Myrvik
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

8.  Antigen from Francisella tularensis: nonidentity between determinants participating in cell-mediated and humoral reactions.

Authors:  G Sandström; A Tärnvik; H Wolf-Watz; S Löfgren
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

9.  Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.

Authors:  E C Gotschlich; I Goldschneider; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

10.  Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants.

Authors:  U Kees; P H Krammer
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

View more
  20 in total

1.  Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity.

Authors:  C M Bosio; K L Elkins
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.

Authors:  H M El Sahly; R L Atmar; S M Patel; J M Wells; T Cate; M Ho; K Guo; M F Pasetti; D E Lewis; M B Sztein; W A Keitel
Journal:  Vaccine       Date:  2009-06-28       Impact factor: 3.641

3.  Mouse models of aerosol-acquired tularemia caused by Francisella tularensis types A and B.

Authors:  David L Fritz; Marilyn J England; Lynda Miller; David M Waag
Journal:  Comp Med       Date:  2014-10       Impact factor: 0.982

4.  Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain.

Authors:  K L Elkins; C M Bosio; T R Rhinehart-Jones
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon.

Authors:  V C Dreisbach; S Cowley; K L Elkins
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

6.  Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis.

Authors:  Meenakshi Malik; Chandra Shekhar Bakshi; Bikash Sahay; Aaloki Shah; Steven A Lotz; Timothy J Sellati
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

7.  Francisella tularensis Infection of Mice as a Model of Sepsis.

Authors:  Charles T Spencer; Mireya G Ramos Muniz; Nicole R Setzu; Michelle A Sanchez Guillen
Journal:  Methods Mol Biol       Date:  2021

8.  Host immune response and acute disease in a zebrafish model of Francisella pathogenesis.

Authors:  Lucia N Vojtech; George E Sanders; Carla Conway; Vaughn Ostland; John D Hansen
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

9.  Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis.

Authors:  Ryan M Troyer; Katie L Propst; Jeff Fairman; Catherine M Bosio; Steven W Dow
Journal:  Vaccine       Date:  2009-05-31       Impact factor: 3.641

10.  Murine T-cell response to native and recombinant protein antigens of Rickettsia tsutsugamushi.

Authors:  C J Hickman; C K Stover; S W Joseph; E V Oaks
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.